---
document_datetime: 2023-09-21 18:34:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vidaza-epar-all-authorised-presentations_en.pdf
document_name: vidaza-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6748272
conversion_datetime: 2025-12-29 19:59:19.870637
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical                      | Route of         | Packaging    | Content   | Package size   |
|-----------------|-----------------|------------|-------------------------------------|------------------|--------------|-----------|----------------|
| EU/1/08/488/001 | Vidaza          | 25 mg/ml   | powder for suspension for injection | subcutaneous use | vial (glass) | 100mg     | 1 vial         |